About 2-methyl-5-[4-[2-(2-methylimidazol-1-yl)ethyl]piperidin-1-yl]-1,3,4-oxadiazole
2-methyl-5-[4-[2-(2-methylimidazol-1-yl)ethyl]piperidin-1-yl]-1,3,4-oxadiazole (PubChem CID 72871457) has the molecular formula C14H21N5O
and a molecular weight of 275.36 g/mol. Its IUPAC name is 2-methyl-5-[4-[2-(2-methylimidazol-1-yl)ethyl]piperidin-1-yl]-1,3,4-oxadiazole.
Analyze 2-methyl-5-[4-[2-(2-methylimidazol-1-yl)ethyl]piperidin-1-yl]-1,3,4-oxadiazole with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-methyl-5-[4-[2-(2-methylimidazol-1-yl)ethyl]piperidin-1-yl]-1,3,4-oxadiazole?
The IUPAC name of 2-methyl-5-[4-[2-(2-methylimidazol-1-yl)ethyl]piperidin-1-yl]-1,3,4-oxadiazole (CID 72871457) is 2-methyl-5-[4-[2-(2-methylimidazol-1-yl)ethyl]piperidin-1-yl]-1,3,4-oxadiazole.
What is the SMILES notation for 2-methyl-5-[4-[2-(2-methylimidazol-1-yl)ethyl]piperidin-1-yl]-1,3,4-oxadiazole?
The canonical SMILES for 2-methyl-5-[4-[2-(2-methylimidazol-1-yl)ethyl]piperidin-1-yl]-1,3,4-oxadiazole is Cc1nnc(N2CCC(CCn3ccnc3C)CC2)o1.
What is the InChIKey of 2-methyl-5-[4-[2-(2-methylimidazol-1-yl)ethyl]piperidin-1-yl]-1,3,4-oxadiazole?
The InChIKey is XEBATFNXPTUVCY-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H21N5O/c1-11-15-6-10-18(11)7-3-13-4-8-19(9-5-13)14-17-16-12(2)20-14/h6,10,13H,3-5,7-9H2,1-2H3.
What are the key properties of 2-methyl-5-[4-[2-(2-methylimidazol-1-yl)ethyl]piperidin-1-yl]-1,3,4-oxadiazole?
2-methyl-5-[4-[2-(2-methylimidazol-1-yl)ethyl]piperidin-1-yl]-1,3,4-oxadiazole has a molecular weight of 275.36 g/mol, XLogP of 2.19, 4 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-methyl-5-[4-[2-(2-methylimidazol-1-yl)ethyl]piperidin-1-yl]-1,3,4-oxadiazole is sourced from PubChem (CID 72871457), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).